Metastatic peritoneal adenocarcinoma is the most likely diagnosis in a patient with malignant ascites.
Although the metastatic rate in this series was 27 %, the prognosis is considered much more favorable than that of other hepatic malignancies.
A structured assessment was carried out of the Novartis economic evaluation of imatinib for unresectable and/or metastatic gist.
One study gave melatonin at night in combination with the drug triptorelin to men with metastatic prostate cancer.
This strategy has recently been shown to be effective for metastatic neuroblastoma.